BOIRON (EPA:BOI) - 2021 HALF-YEAR BOIRON ACTIVITY

Transparency directive : regulatory news

21/07/2021 15:15

Cumulative Activity as of the end of june 2021

In thousands of euros 2020 2021 Variation at current
exchange rates
Variation at constant
exchange rates
France 104,930 126,323 -16.9% -16.9%
Europe (excluding France) 42,234 54,485 -22.5% -20.8%
North America 35,380 61,365 -42.3% -37.6%
Other countries 7,388 11,460 -35.5% -30.2%
Group total 189,931 253,633 -25.1% -23.4%

 

In thousands of euros 2020 2021 Variation at current
exchange rates
Variation at constant
exchange rates
Non-proprietary Homeopathic Medicines 93,994 110,055 -14.6% -13.6%
OTC Specialties 95,188 142,917 -33.4% -31.0%
Other 749 660 +13.5% +14.4%
Group total 189,931 253,633 -25.1% -23.4%

 

Activity by quarter (variation at current exchange rates)

In thousands of euros 1st quarter 2nd quarter
2021 2020 Var. 2021 2020 Var.
France 51,518 72,820 -29.3% 53,412 53,503 -0.2%
Europe (excluding France) 20,039 37,581 -46.7% 22,194 16,904 +31.3%
North America 17,657 40,272 -56.2% 17,723 21,094 -16.0%
Other countries 1,958 5,960 -67.2% 5,430 5,500 -1.3%
Group total 91,172 156,633 -41.8% 98,759 97,000 +1.8%

 

In thousands of euros 1st quarter 2nd quarter
2021 2020 Var. 2021 2020 Var.
Non-proprietary Homeopathic Medicines 46,352 61,722 -24.9% 47,642 48,334 -1.4%
OTC Specialties 44,571 94,619 -52.9% 50,617 48,298 +4.8%
Other 249 292 -14.8% 500 368 +36.0%
Group total 91,172 156,633 -41.8% 98,759 97,000 +1.8%

 

Change in revenue

In the second quarter:

  • Following a sharp 41.8% decline in the first quarter, revenues returned to growth of 1.8%.
  • Sales stabilized in France and rose sharply in Europe (particularly in Russia).
  • The decline in sales of non-proprietary medicines significantly slowed to 1.4%, essentially due to the basis for comparison.
  • Specialty sales rose 4.8%, thanks in particular to the marketing of new products, including the marketing of rapid Sars-Cov2 antigen tests using a nasal swab for self-testing.

Over the first half:

  • Total sales in the first half were down 25.1%, significantly impacted by the decline in the first quarter due to the delisting of homeopathic medicines in France and the global health crisis.
  • Sales of new products amounted to approximately €15 million.

 

Reorganization plan

In France, the reorganization plan began in January and is on schedule. Twelve preparation-distribution sites (of 27) closed during the first half and the Montrichard site will close at the end of the year.

 

Outlook

Given the sharp decline in revenues, the operating income in the first half, which is currently being consolidated, will result in a loss.

We expect to see a further decline in sales of non-proprietary medicines in the second half of the year following the delisting of homeopathic medicines in France. Specialty sales are forecasted to improve, although this will depend on the duration and extent of impacts of the health crisis. We expect to see a significant decline in revenues over the year.

Full-year operating income will benefit from the comparison effect of the reorganization in France provisioned in 2020, as well as initial savings generated by the reorganization and continued savings on operating expenses. It will also be boosted by the positive contribution of new product sales. We therefore expect to post positive annual operating income, although down versus 2020 given the drop in revenues in the first quarter.

We continue to do our utmost to preserve access to homeopathic medicines for all patients, and to develop homeopathy throughout the world.

Laboratoires BOIRON


Our next update: September 8, 2021: at market close, publication of 2021 half-year results.
Person responsible for financial information: Valérie Lorentz-Poinsot.
Contact for financial information: Fabrice Rey.
Investor relations: +33 (0) 4.37.41.84.01 - e-mail:
boironfinances@boiron.fr
ISIN Code: FR0000061129 (BOI) - Bloomberg: BOI FP - Reuters: BOIR.PA
The group's financial information and the glossary are online at: www.boironfinance.com



This publication embed "Actusnews SECURITY MASTER".
- SECURITY MASTER Key: x5qfkcpqk2bGmnFylJtpaWZjamdpmJKabpLHxmNrlpqacGlkymhlb5SbZnBhmGpn
- Check this key: https://www.security-master-key.com.



Regulated information:
Inside Information:
- other releases


Full and original press release in PDF: https://www.actusnews.com/news/70351-gb_avis-financier_activite_s1-2021.pdf

Receive by email the next press releases of the company by registering on www.actusnews.com, it's free

21/07/2021 15:15
28/06/2021 15:00
22/04/2021 17:45
10/03/2021 17:45
21/01/2021 17:45
22/10/2020 17:45
15/10/2020 10:00
09/09/2020 17:40
24/04/2020 10:30
07/04/2020 18:15

BOIRON's latest news


21/07/2021 15:15
28/06/2021 15:00
22/04/2021 17:45
10/03/2021 17:45
21/01/2021 17:45
22/10/2020 17:45
15/10/2020 10:00
09/09/2020 17:40
24/04/2020 10:30
07/04/2020 18:15


Other stories

02/08/2021 19:40
02/08/2021 13:15
02/08/2021 18:16
02/08/2021 19:41
02/08/2021 15:58
02/08/2021 10:28
02/08/2021 18:15
02/08/2021 15:56
02/08/2021 16:37
02/08/2021 12:57
02/08/2021 14:56
02/08/2021 11:35
02/08/2021 15:20
02/08/2021 08:20
02/08/2021 16:57
02/08/2021 09:43
02/08/2021 17:50
02/08/2021 13:47
02/08/2021 18:12
02/08/2021 12:54
02/08/2021 14:15
02/08/2021 07:00
02/08/2021 13:57
02/08/2021 16:18
02/08/2021 17:26
02/08/2021 15:32
02/08/2021 19:15
02/08/2021 18:25
02/08/2021 19:00
02/08/2021 17:26
02/08/2021 17:25
02/08/2021 09:26
02/08/2021 12:25
02/08/2021 17:00
02/08/2021 11:14
02/08/2021 19:20
01/08/2021 20:19
02/08/2021 06:00